Effects of erdosteine on bleomycin-induced lung fibrosis in rats

被引:37
|
作者
Boyaci, H
Maral, H
Turan, G
Basyigit, I
Dillioglugil, MÖ
Yildiz, F
Tugay, M
Pala, A
Erçin, C
机构
[1] Kocaeli Univ, Sch Med, Dept Pediat Surg, Kocaeli, Turkey
[2] Kocaeli Univ, Sch Med, Dept Pathol, Kocaeli, Turkey
[3] Kocaeli Univ, Sch Med, Dept Biochem, Kocaeli, Turkey
[4] Kocaeli Univ, Sch Med, Dept Chest Dis, Kocaeli, Turkey
关键词
bleomycin; erdosteine; lung; nitric oxide;
D O I
10.1007/s11010-006-0640-3
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
This study was designed to examine the effects of erdosteine on bleomycin (BLM)-induced lung fibrosis in rats. Thirty-three Sprague-Dawley rats were divided randomly into three groups, bleomycin alone (BLM), bleomycin+erdosteine (BLM+ERD), and saline alone (control). The BLM and BLM+ERD groups, were given 2.5 mg/kg BLM intratracheally. The first dose of oral erdosteine (10 mg/kg/day) in the BLM+ERD group was started 2 days before BLM administration and continued until animals were sacrificed. Animals were sacrificed 14 days after intratracheal instillation of BLM. The effect of erdosteine on pulmonary fibrosis was studied by analysis of bronchoalveolar lavage (BAL) fluid, histopathology, and biochemical measurements of lung tissue superoxide dismutase (SOD) and glutathione (GSH) as antioxidants, malondialdehyde (MDA) as an index for lipid peroxidation, and nitrite/nitrate levels. Bleomycin-induced lung fibrosis as determined by lung histology was prevented with erdosteine (grades of fibrosis were 4.9, 2.3, and 0.2 in BLM, BLM+ERD, and control groups, respectively). Erdosteine also prevented bleomycin-induced increase in MDA (MDA levels were 0.50 +/- 0.15, 0.11 +/- 0.02, and 0.087 +/- 0.03 nmol/mg protein in BLM, BLM+ERD, and control groups, respectively) and nitrite/nitrate (nitrite/nitrate levels were 0.92 +/- 0.06, 0.60 +/- 0.09, and 0.56 +/- 0.1 mu mol/mg protein in BLM, BLM+ERD, and control groups respectively) levels. Bleomycin-induced decrease in GSH and SOD levels in the lung tissue also prevented by erdosteine [(GSH levels were 213.5 +/- 12.4, 253.2 +/- 25.2, and 287.9 +/- 34.4 nmol/mg protein) (SOD levels were 1.42 +/- 0.12, 1.75 +/- 0.17, and 1.89 +/- 0.09 U/mg protein) in BLM, BLM+ERD, and control groups respectively]. Erdosteine prevented bleomycin-induced increases in total cell number and neutrophil content of the BAL fluid. In conclusion, oral erdosteine is effective in prevention of BLM-induced lung fibrosis in rats possibly via the repression of neutrophil accumulation, inhibition of lipid peroxidation, and maintenance of antioxidant and free radical scavenger properties.
引用
收藏
页码:129 / 137
页数:9
相关论文
共 50 条
  • [41] Plumbagin attenuates Bleomycin-induced lung fibrosis in mice
    Mehdizadeh, Saber
    Taherian, Marjan
    Bayati, Paria
    Mousavizadeh, Kazem
    Pashangzadeh, Salar
    Anisian, Ali
    Mojtabavi, Nazanin
    ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2022, 18 (01):
  • [42] THE EFFECT OF DEFEROXAMINE ON BLEOMYCIN-INDUCED LUNG FIBROSIS IN THE HAMSTER
    CHANDLER, DB
    FULMER, JD
    AMERICAN REVIEW OF RESPIRATORY DISEASE, 1985, 131 (04): : 596 - 598
  • [43] Emodin alleviates bleomycin-induced pulmonary fibrosis in rats
    Guan, Ruijuan
    Zhao, Xiaomei
    Wang, Xia
    Song, Nana
    Guo, Yuhong
    Yan, Xianxia
    Jiang, Liping
    Cheng, Wenjing
    Shen, Linlin
    TOXICOLOGY LETTERS, 2016, 262 : 161 - 172
  • [44] Gefitinib prevents bleomycin-induced lung fibrosis in mice
    Ishii, Yoshiki
    Fujimoto, Sakae
    Fukuda, Takeshi
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (05) : 550 - 556
  • [45] NIACIN ATTENUATES BLEOMYCIN-INDUCED LUNG FIBROSIS IN THE HAMSTER
    WANG, QJ
    GIRI, SN
    HYDE, DM
    NAKASHIMA, JM
    JAVADI, I
    JOURNAL OF BIOCHEMICAL TOXICOLOGY, 1990, 5 (01): : 13 - 22
  • [46] THE EFFECT OF ENDOTOXIN ON BLEOMYCIN-INDUCED LUNG FIBROSIS IN THE RAT
    BRIGGS, AD
    CHANDLER, DB
    JACKSON, RM
    FULMER, JD
    TOXICOLOGY LETTERS, 1985, 27 (1-3) : 91 - 96
  • [47] Losartan attenuates bleomycin-induced pulmonary fibrosis in rats
    Yao, HW
    Zhu, JP
    Zhao, MH
    Lu, Y
    RESPIRATION, 2006, 73 (02) : 236 - 242
  • [48] Montelukast As A Treatment For Bleomycin-Induced Lung Fibrosis In Mice?
    Willems, S.
    Somers, J.
    Verleden, S. E.
    Vanaudenaerde, B. M.
    Verleden, G. M.
    Wuyts, W.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2011, 183
  • [49] ASTRAGALOSIDE ALLEVIATES BLEOMYCIN-INDUCED PULMONARY FIBROSIS IN RATS
    Yu, Wei-Na
    Sun, Li-Feng
    Yang, Hua
    ACTA MEDICA MEDITERRANEA, 2017, 33 (06): : 1151 - 1156
  • [50] LUNG CYTOKINE PRODUCTION IN BLEOMYCIN-INDUCED PULMONARY FIBROSIS
    PHAN, SH
    KUNKEL, SL
    EXPERIMENTAL LUNG RESEARCH, 1992, 18 (01) : 29 - 43